UNRESOLVED ISSUES AND PERSPECTIVES OF ANTICANCER DRUG THERAPY С

chemotherapy, targeted therapy, monoclonal antibodies, tyrosine kinase inhibitors, conjugated monoclonal antibodies, resistance to anticancer therapy.

Authors

Publication Details

Journal
Practical oncology
Published
2024-12-30
DOI
https://doi.org/10.31917/2504303
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UNRESOLVED ISSUES AND PERSPECTIVES OF ANTICANCER DRUG THERAPY С

S.А. Tjulandin, Olga Kuznetsova
Practical oncology
PARP inhibition in cancer therapy
article

UNRESOLVED ISSUES AND PERSPECTIVES OF ANTICANCER DRUG THERAPY С

S.А. Tjulandin, Olga Kuznetsova
article en

Abstract

chemotherapy, targeted therapy, monoclonal antibodies, tyrosine kinase inhibitors, conjugated monoclonal antibodies, resistance to anticancer therapy.

Practical oncologyVol. 25(4)
Openalex Percentile: Top 57%
PARP inhibition in cancer therapy
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.